NCT02291055 2023-03-20A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck CancerAdvaxis, Inc.Phase 1/2 Terminated75 enrolled 23 charts
NCT01975831 2022-10-12A Phase 1 Study to Evaluate MEDI4736 in Combination With TremelimumabLudwig Institute for Cancer ResearchPhase 1 Completed104 enrolled 23 charts